LEXON
13.4.2021 09:32:11 CEST | Business Wire | Press release
Lexon today announced that it has received 6 Red Dot Awards for its outstanding product design quality in multiple categories, setting a new company record for the number of awards won in a single competition. Sister company MyKronoz also takes home a Red Dot Award for its MyScale , a smart and design body scale with a large and intuitive color display.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210413005520/en/
This announcement comes only a few weeks after Lexon’s best-selling Oblio was honored with two prestigious international prizes - a TIME Best Invention Award and a CES Innovation Award - confirming the French brand’s continued leadership in innovative product design, with a total of more than 200 awards received since its creation in 1991.
“2021 marks the 30th anniversary of Lexon, so this exceptional recognition comes at a perfect timing. We couldn’t be happier to celebrate this milestone with such paramount achievement which proves our consistent ability to create objects that combine aesthetics and function, but most importantly, that are part of our daily lives.
2021 is also synonymous with the global crisis, one that inevitably led us to adapt our business to new realities, to rethink our products portfolio and to focus even more on designing solutions that truly meet our changing environments, whether it’s for the home, the work or the new mobility.
Today, these distinctions not only celebrate our resilience, they also validate the quality of the experience we strive to bring to our customers in all circumstances,” says Boris Brault, Lexon’s CEO.
Since its acquisition by BOW Group in 2018, Lexon has experienced significant online growth and staggering expansion in the US where the brand is today listed among the most prominent retailers including Target, Nordstrom, Neiman Marcus, Best Buy and MoMA Design Store. In the coming weeks, Lexon will pursue its international development by completing the takeover of its long-term Chinese Master License who has built the brand domestically for the past 10 years, opening more than 80 retail stores, developing online sales on JD.com and Taobao, as well as growing profitable B2B activities.
The successful integration of Lexon among BOW Group has created highly valuable synergies with sister company MyKronoz, in terms of product design, R&D capabilities, sales channels and digitalization. BOW Group has thereby proven its ability to acquire external companies within its manufacturing, selling and distribution structures to scale its business operations. Today, the Group is looking at new opportunities to further enlarge its portfolio with product offering and services, in order to become a leading 360° platform of lifestyle consumer tech.
The Lexon award-winning products include:
Oblio :
A must-have innovation for today’s world, Oblio is a sleek UV-C sanitizer that prevents the spread of harmful bacteria found on our smartphones. Using its built-in UV-C LED technology located on its front interior, Oblio can deliver a 360° disinfection by simply flipping the phone to expose each surface for a 20-minute sanitizing cycle. Oblio’s efficiency has been proven through lab testing to kill 99.9% of viruses present on the surface of smartphones, including H1N1.
Also acting as a 10W wireless charger, Oblio can fully charge a smartphone in 3 hours. Its discrete vase-like shape makes it a beautiful design item that can be proudly displayed in a home or office, encouraging a break from your screen while your phone is being fast-charged and deeply sanitized.
Compatible with all mobile phones for sanitizing function, and all Qi-enabled smartphones such as the latest iPhone & Android devices for the wireless charging function.
MSRP: 79.90 $/€
Mino T : Made for exploring, Mino T is an outdoor speaker designed with a sleek carabiner to clip to your bag or bike. Boasting an IPX4 water resistance combined with an ultra-robust finish, it is ready to follow you in all your adventures. Carefully engineered with a passive bass system, Mino T allows you to enjoy a more balanced, fuller sound on the go with up to 5h of continuous playtime. Built with a considered design in mind, this speaker is also a stand-alone modern piece that you can proudly display indoors, on its matching stand.
MSRP: 49.90 $/€
Mina M :
With its compact size, statement-making aluminum base and water-resistant casing, the Mina M is the perfect way to inspire any space, indoor and out. Mina M brings an impressive 9 LED light color range to your bedside, workspace, or patio. The color change and dimming function are all controlled by a press down feature on the top of the light. Mina M is rechargeable using any Qi-enabled wireless charging station. You can also charge Mina M by using a USB-C charging cable. The Mina M has up to 24h of battery life from a single charge, making it the perfect companion all day and night.
MSRP: 49.90 $/€
Mino+ :
This mini portable Bluetooth® speaker fits in the palm of your hand to deliver an impressive 3W sound quality for up to 3 hours! Mino+ offers two charging methods: wirelessly with any Qi charging pad or via its USB-C port. When connected to your phone, you can use Mino+ to take selfies, start and stop recording videos, and answer calls using the bottom button.
Thanks to its built-in TWS technology, you can connect two Mino+ together and double the pleasure with an immersive stereo sound. Mino+ comes in 3 finishes (aluminum, chrome and glossy) and 24 colors to bring a stylish touch to your decor.
MSRP: 29.90 $/€
These four products have been designed in collaboration with Manuela Simonelli & Andrea Quaglio.
No connector, no cable: PowerSound is a revolutionary 2-in-1 device that combines a 5000 mAh wireless power bank with a 360° Bluetooth speaker, while charging and recharging itself entirely wirelessly. Capable of charging all Qi-enabled smartphones or earbuds, it can be recharged by setting it on top of any wireless station. Thanks to its 5W built-in Bluetooth® speaker, PowerSound allows you to enjoy an immersive sound for up to 20 hours. Easy to carry and ultra-stylish, PowerSound has a smooth design crafted from durable synthetic leather and fabric.
MSRP: 79.90 $/€
C-Pen :
The C-Pen offers a unique 2-in-1 writing and storage experience. A ballpoint pen with a 32 GB USB-C memory drive thoughtfully engineered into the pencap. 32 GB of memory means you can transfer and store up to 4000 pictures, 7000 songs, or 40 hours of video. Compatible with computers, tablets, and smartphones with a USB-C port, the C-Pen is a handy way to transfer memories or notes between all your devices. The must have accessory for the modern on-the-go person, available in 6 colors in a glossy or matt finish and working with a universal refill.
MSRP:39.90 $/€
These two products have been designed in collaboration with Alain Berteau.
About the Red Dot Award:
The Red Dot Award - Product Design, whose origins date back to 1955, appraises the best products created every year. In roughly 50 categories , manufacturers and designers can enter their innovations in the competition. According to the motto “In search of good design and innovation”, the jury evaluates the entries and only awards a Red Dot to products that win them over with their high design quality.
About Lexon:
Since its creation in 1991, Lexon has relentlessly pushed the limits and created a difference in the world of design while remaining true to its commitment to make small objects useful, beautiful, innovative and affordable. Whether in electronics, audio, travel accessories, office or leisure, Lexon has established a special relationship with creativity and partnered with the best designers around the world to create timeless collections of lifestyle products. Following its recent acquisition by BOW Group, a global player in the lifestyle and wearable consumer markets, Lexon is writing a new chapter in its history, experiencing a staggering international growth and digital expansion. Today, with 30 years of existence, more than 200 awards, collaboration with some of the most renowned designers, a retail presence in more than 90 countries across the Globe, Lexon has truly established itself as a worldly-known French design brand.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210413005520/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press release
Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation at ESMO 2026Arcotatug Tavatecan Met Dual Primary Endpoints of Overall Survival and Progression-Free Survival, Showing Significant Improvements vs. Treatment of Physician’s Choice in Patients with Previously Treated CLDN18.2-Positive Advanced Gastric CancerFindings to Support Planned Regulatory Filing in Japan and Continued Global Development of Arcotatug Tavatecan in CLDN18.2-Positive Cancers Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
